Psoriasis in Latin America

Race in Latin America

category to understand human biological diversity. Humans vary to some extent in their DNA and their outward physical appearance or phenotype, but this diversity cannot be organized into “racial groups” or “races,” even if some genetic and phenotypical variation seems to correlate very broadly with continental geography. Humans are too similar genetically and intracontinental genetic variation ...

Stigma in Latin America

Despite the fact there has been difficulty in developing a theory of stigma that is specific to patients with mental disorders, a multidisciplinary effort has been made to understand its impact (Smith, 2002). The key element in the social origins of stigma is the perception of difference, in particular societal concerns that people with mental disorders, who often have communication problems, h...

Dementia in Latin America

The demographic structure of Latin American countries (LAC) is fast approaching that of developing countries, and the predicted prevalence of dementia in the former already exceeds the latter. Dementia has been declared a global challenge, yet regions around the world show differences in both the nature and magnitude of such a challenge. This article provides evidence and insights on barriers w...

Housing in Latin America

Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America.

Latin American countries view biosimilar agents as an effective approach to curtail health-care expenditures while maintaining the safety and efficacy profile of their branded innovator comparators. To understand the complexities of the regulatory landscape and key therapeutic issues for use of biosimilars to treat moderate to severe psoriasis in Latin America, the International Psoriasis Counc...